* Surgery Partners, Inc. SGRY.OQSGRY.O is expected to
show a rise in quarterly revenue when it reports results on
August 10 for the period ending June 30 2026
* The Brentwood Tennessee-based company is expected to
report a 0.5% increase in revenue to $830.366 million from
$826.2 million a year ago, according to the mean estimate from
11 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Surgery Partners, Inc.
is for earnings of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," 3 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last three months.
* Wall Street's median 12-month price target for Surgery
Partners, Inc. is $19.50, about 30.7% above its last closing
price of $14.92
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2026 -0.11 -0.12 -0.03 Beat 74.3
Dec. 31 2026 0.31 0.30 0.12 Missed -60
Sep. 30 2025 0.16 0.17 0.13 Missed -21.5
Jun. 30 2025 0.13 0.13 0.17 Beat 26.6
Mar. 0.06 0.05 0.04 Missed -22.8
31 2025
Dec. 31 2024 0.37 0.38 0.44 Beat 17.3
Sep. 30 2024 0.26 0.25 0.19 Missed -24.6
Jun. 30 2024 0.20 0.20 0.21 Beat 5
This summary was machine generated August 7 at 16:14 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)